Next Article in Journal
An On-Demand Drug Delivery System for Control of Epileptiform Seizures
Next Article in Special Issue
A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)
Previous Article in Journal
The 3D Bioprinted Scaffolds for Wound Healing
Previous Article in Special Issue
Genipin-Crosslinked, Proteosaccharide Scaffolds for Potential Neural Tissue Engineering Applications
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 465; https://doi.org/10.3390/pharmaceutics14020465
Action Date Notes Link
article pdf uploaded. 21 February 2022 14:24 CET Version of Record https://www.mdpi.com/1999-4923/14/2/465/pdf-vor
article xml file uploaded 22 February 2022 10:43 CET Original file -
article xml uploaded. 22 February 2022 10:43 CET Update -
article pdf uploaded. 22 February 2022 10:43 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/465/pdf-vor
article html file updated 22 February 2022 11:15 CET Original file -
article html file updated 22 February 2022 11:15 CET Update -
article xml file uploaded 24 February 2022 03:28 CET Update -
article xml uploaded. 24 February 2022 03:28 CET Update https://www.mdpi.com/1999-4923/14/2/465/xml
article pdf uploaded. 24 February 2022 03:28 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/465/pdf
article html file updated 24 February 2022 03:30 CET Update -
article html file updated 1 August 2022 01:50 CEST Update https://www.mdpi.com/1999-4923/14/2/465/html
Back to TopTop